KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 198 filers reported holding KRYSTAL BIOTECH INC in Q4 2023. The put-call ratio across all filers is 2.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $35,169,815 | -9.2% | 191,515 | -12.0% | 0.17% | -11.1% |
| Q1 2024 | $38,743,724 | +28.0% | 217,747 | -10.8% | 0.19% | +8.6% |
| Q4 2023 | $30,278,208 | +106848.6% | 244,061 | 0.0% | 0.18% | -5.9% |
| Q3 2023 | $28,311 | -15.6% | 244,061 | -14.6% | 0.19% | -15.5% |
| Q2 2023 | $33,560 | +46.6% | 285,860 | -0.1% | 0.22% | +37.5% |
| Q1 2023 | $22,899 | +0.5% | 286,018 | -0.5% | 0.16% | -6.4% |
| Q4 2022 | $22,779 | -99.9% | 287,541 | -3.4% | 0.17% | +6.9% |
| Q3 2022 | $20,743,000 | +6.2% | 297,610 | 0.0% | 0.16% | +11.1% |
| Q2 2022 | $19,541,000 | +40.7% | 297,610 | +42.6% | 0.14% | +75.6% |
| Q1 2022 | $13,888,000 | -5.7% | 208,711 | -0.1% | 0.08% | +7.9% |
| Q4 2021 | $14,722,000 | +112.0% | 208,826 | +57.0% | 0.08% | +100.0% |
| Q3 2021 | $6,944,000 | -19.1% | 133,001 | +5.3% | 0.04% | -28.3% |
| Q2 2021 | $8,588,000 | +718.7% | 126,292 | +827.2% | 0.05% | +657.1% |
| Q1 2021 | $1,049,000 | – | 13,621 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 895,000 | $38,530,000 | 3.46% |
| S Squared Technology, LLC | 80,215 | $3,453,000 | 2.57% |
| First Light Asset Management, LLC | 464,663 | $20,004,000 | 2.05% |
| Redmile Group, LLC | 1,501,945 | $64,659,000 | 1.19% |
| Nicholas Investment Partners, LP | 222,422 | $9,575,000 | 1.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 184,573 | $7,946,000 | 0.78% |
| HighMark Wealth Management LLC | 18,894 | $813,000 | 0.73% |
| Hood River Capital Management LLC | 257,203 | $11,073,000 | 0.48% |
| GARNET EQUITY CAPITAL HOLDINGS, INC. | 40,000 | $1,722,000 | 0.35% |
| Artal Group S.A. | 237,500 | $10,224,000 | 0.25% |